GBI Research

GBI Research publishes in-depth strategic intelligence reports on the #healthcare sector. #pharma #marketresearch #healthinnovations

[GBI Research @GBIResearch]

We provide in-depth strategic intelligence reports on the #lifesciences sector and #healthcare industry. Browse our Report Store here: https://t.co/7GgJjNLWwp

[GBI Research @GBIResearch]

The #rheumaticdisorder #therapy area is multi-disciplinary in nature and encompasses conditions that affect joints, connective tissue, ligaments, tendons, cartilage, bone and muscle: https://t.co/BsX0bsxIV5 #pharma #marketresearch

[GBI Research @GBIResearch]

Do you remember when you joined Twitter? I do! #MyTwitterAnniversary

[GBI Research @GBIResearch]

The eyes have it: #IND for the first CRISPR #genetherapy approved in Leber Congenital Amaurosis: https://t.co/oPJwODRCfa #marketresearch #healthinnovations

[GBI Research @GBIResearch]

Register now for this interesting #pharma webinar on #digital #healthcare

[GlobalData Healthcare @Healthcare_GD]

Learn what #technologies are set to disrupt #healthcare in our upcoming Expert Presentation, #Digital Disruption in Healthcare! Sign up now: https://t.co/ZTdLh9gRod

[GBI Research @GBIResearch]

The #RebateWall poses an important challenge for #biosimilar uptake in the US. If the proposal from the Trump administration to remove rebates is successful, this could have a significant impact on the entire #pharma industry: https://t.co/71ZtP12AeS

[GBI Research @GBIResearch]

With 9,269 molecules #oncology is the leading #therapy area in the #pharmaceutical pipeline. Advancements in #cancerresearch and #innovation have made it possible to produce large number of pipeline molecules in most oncology indications: https://t.co/s8dbSxDKDs

[GBI Research @GBIResearch]

The market size for #rheumaticdisorder therapeutics is expected to grow from $58.97 billion in 2017 to $80.04 billion in 2024, at a CAGR of 4.46%. Which products will contribute to #market growth most, and which will achieve #blockbuster status? https://t.co/BsX0bsxIV5

[GBI Research @GBIResearch]

Industry pipeline for #womenshealth comprises 277 programs in active #clinical development: https://t.co/flyOYxMclJ

[GBI Research @GBIResearch]

Global #WomensHealth market size set to grow rapidly to $36.8 billion in 2024 - our report focuses on #endometriosis #PCOS #CIN, #menopausal disorders and #infertility: https://t.co/flyOYxMclJ

[GBI Research @GBIResearch]

Although #pharmaceutical innovation is moving towards #biologics, small molecules are still favored by the industry, with 9980 small molecules in the pipeline: https://t.co/s8dbSxDKDs #pharma #marketresearch

[GBI Research @GBIResearch]

#HPV #vaccines continue to dominate #cancer vaccines landscape: https://t.co/OV8UwI6KkO

[GBI Research @GBIResearch]

The next wave of #genetherapies will involve targeted #genomic surgery: https://t.co/oPJwODRCfa #pharmaceutical #marketresearch

[GBI Research @GBIResearch]

Today's the day, register for GlobalData's #OUD presentation now!

[GlobalData Healthcare @Healthcare_GD]

Last chance to sign up for our #OpioidUseDisorder presentation tomorrow! Click here to register - https://t.co/v65ExhYTJE

[GBI Research @GBIResearch]

The global #biosimilar market is poised to witness a wave of #biosimilars approvals in the coming years as 24% of the pipeline products are in late stage of development: https://t.co/71ZtP12AeS #marketresearch #pharma

[GBI Research @GBIResearch]

How does the global #biosimilar #pipeline look like in 2018? https://t.co/71ZtP12AeS #pharma #healthcare #marketresearch

[GlobalData Healthcare @Healthcare_GD]

Don't forget to register for our #Opioid Use Disorder Expert Presentation next week! #OUD #healthcare https://t.co/4oVfqdd3ru

[GBI Research @GBIResearch]

Our latest report provides a comprehensive overview of the emerging #genetherapy market: https://t.co/oPJwODRCfa #genes #pharma #healthcare #marketresearch

[GlobalData Healthcare @Healthcare_GD]

Find out all about the changing #Opioid Use Disorder treatment landscape in our Expert Presentation - sign up now! #OUD https://t.co/rDPfMuJcma

[GBI Research @GBIResearch]

What is the current size and composition of the #pharmaceutical industry #pipeline and how has it changed in the last 4 years? What can we learn from this? Find out in our latest report: https://t.co/s8dbSxDKDs

[GBI Research @GBIResearch]

The first janus kinase inhibitors to be approved for #dermatological indications are expected to enter the market in the next few years: https://t.co/QvZuCOkPT5 #dermatology #drugs #marketresearch #pharma